Bio-Technology News from StratCenter.com News Archive
StratWire - Complete Business of BioTech Newsfeed
http://www.myhealthcarenews.com/RSS/HCC0019.xml
Page: 2 of 30 
- Applied Films Announces 1st Order for New SMARTWEB Sputtering System
- 12.5M in Stock Buys RTP's Icoria: Mass.-Based Clinical Data Deal in the Works
- GenVec Shares Down on Planned Stock Sale
- Clinical Data to buy NC biotech in $12.5M stock deal
- Icoria sold for $12.5M
- ViaCell to Present at UBS Healthcare Conference
- Vertex Pharmaceuticals Announces Webcast of its Presentation at the 2005 UBS Global Life Sciences Conference
- Institute of Systems Biology Adopts Kreatech Biotech 's ULS Nucleic Acid Labeling Technology in a Collaboration on New Assays
- Stock up on sale of brain treatment
- CytRx cleared for Phase II drug trial
- Wyeth to Present at the UBS Global Life Sciences Conference
- Cellerant Therapeutics gets $9M in new funding
- GTx [GTXI] CEO to Ring The NASDAQ Stock Market Opening Bell
- Antigenics CEO to Present at UBS Global Life Sciences Conference
- BioMed Realty Trust Acquires San Diego Property From Isis Pharmaceuticals in Sale-Leaseback Transaction; Adds 6th Property in San Francisco
- PAREXEL Announces Date of Q1 Earnings Release and Conference Call
- ACADIA Pharmaceuticals Study Identifies Molecular Properties of ACP-104 That Predict Unique Antipsychotic Activity
- BioTech Medics Assets Increase Over 400%
- Drug stocks fall; Alkermes hit by delay
- Myriad Study Shows Alzheimer's Slowing
- GenVec to raise $14.5M in stock sale
- CytRx Initiates Phase II Clinical Trial With Arimoclomol for Treating ALS
- Legal Opinion Reinforces Cobalis Patent
- Momenta Pharmaceuticals to Present at UBS Global Life Sciences Conference
- Gilead Sciences to Present at the 2005 UBS Global Life Sciences Conference, September 27th
- Biotech Holdings private placement funds used to continue Sucanon advertising
- Sigma-Aldrich to Present at the Credit Suisse 1st Boston Chemical Conference, 9/27/2005
- Market Pulse: Kensey Nash seeks FDA approval to study new use of TriActiv
- Flamel Interferon Lowers Side Effects
- Genentech Stops Enrolling Avastin Study
- Biotech Firm Gambles on New Plant
- Indexes diverge modestly, Genentech dips on drug news
- Intarcia Therapeutics yanks IPO
- Diosynth lands deal to make drug for Vernalis
- GTx Delays Planned Stock Sale
- Market Pulse: GTx delays proposed sale of 5M common shares
- Biomira Delays Lung Cancer Study Start
- GTx Announces Delay of Public Offering of Common Stock
- Crucell Clarifies CFO Comment Made at UBS Conference
- Market Pulse: Nabi Pharma sues Roxane Labs over gelcap patent
- President's letter notes expansion of Sucanon distribution in Mexico
- Tramford Proposed to Acquire Bio-Technology Corp and Convened 2005 Annual Meeting
- Manhattan Research Reveals the Top 5 Traits of the 'Ideal' eDetail
- Halozyme Therapeutics Presents Novel Stroke Data at the 2005 American Neurological Assoc Annual Meeting
- Nabi Biopharmaceuticals Files Lawsuit for Infringement of its PhosLo Gelcap Patent
- IMI changes name to PreMD
- Biotech industry cries foul over NYSE postponing LSR's listing
- Valentis to Web Cast Corporate Update
- Palatin Gets $10 mln From King
- Market Pulse: Immune Response gets OK to start IR103 trial in Italy
- The Immune Response Corp Cleared to Initiate New IR103 Study in HIV Drug-Naive Patients in Italy
- Former HHS Secretary Thompson to Headline BIO/Burrill Personalized Medicine Event
- Market Pulse: Elan units begin offer to exchange up to $1.15B of notes
- Market Pulse: ArQule decides to exit its chemistry services business
- NeoRx averts delisting by NASDAQ
- Ventiv Health to Announce Q3 2005 Results and Conduct Conference Call, 11/8/2005
- Mid-Atlantic Bio Conference Poised To Unite Bioscience Community And Enhance Visibility Of Regional Companies
- DiObex Receives Fast-Track Status From FDA for VLD-Glucagon
- Midwest Will Be Next Biotech Hotbed
- DelSite Biotechnologies, Carrington Subsidiary, Presents th Anniversary Drug Delivery Technologies and Deal-Making Summit
- Genentech Receives Patent Rejection
- NNE Builds New Vaccine Facility for Bavarian Nordic in Record Time
- Biotech Shares Get Boost From Results
- Beckman Coulter Launches New Agencourt DNA Isolation Kit
- XTLbio has Initiated the Phase 1a Clinical Trial of XTL-6865 for the Treatment of Hepatitis C
- PDI Selected by Ferring to Promote EUFLEXXA
- PA Supports Neotropix Expansion in Malvern With $50,000 Investment; Project Will Create and Retain 30 Jobs in Chester County
- Oncolytics Biotech to Present at the Sachs-Bloomberg 5th Annual Biotech in Europe Investor Forum
- Fritzky Family 'Gives Back' to Pittsburgh's OH Valley General Hospital
- Antares Pharma to Present at BioContact Conference in Quebec, Canada
- 3rd Annual BIO Mid-America VentureForum Draws Record Investor Attendance
- Flynn in as PA Bio head
- Crucell Files Financial Statements with Euronext for H1 2005 in Accordance with IFRS
- Wyeth Makes Debut Amongst Top 20 Biotech and Pharmaceutical Employers in Science Magazine 2005 Survey
- Human Genome Supplying ABthrax for Tests
- Market Pulse: Metabasis raises $41.3M in stock/warrants private placement
- The Immune Response Corp Receives Nasdaq Notice of Potential Delisting
- Strong Bioscience Showing Enriches CT Technology Alliance Event
- Crucell to Release Q3 Results, 10/17/2005
- OXiGENE Expands Int'l Footprint
- Webcast Alert: Provectus Pharmaceuticals Presentation at Informed Investors Biotech / Cancer On-line Investor Forum webcast, 10/6/2005,
- Bioniche Retains Blackmont Capital to Assist in Sale of Pharma Business Unit
- Caliper Life Sciences Completes Acquisition of NovaScreen Biosciences
- Market Pulse: Cytogen sales fall short of expectations
- Cytogen Warns of 2005 Revenue Shortfall
- Procyon to present at 3 healthcare conferences this fall
- Cytogen Corp Updates 2005 Financial Guidance
- MGI Pharma completes Guilford deal
- Viventia to present at BioContact 2005
- Biotech Posts Strong Q3
- Stem Cells Files to Sell Common Stock
- Webcast Alert: Tapestry Pharmaceuticals Presentation at Informed Investors Biotech / Cancer On-line Investor Forum webcast, 10/6/2005,
- Cytogen Warns of 2005 Revenue Shortfall
- XenoPort is poised for growth after IPO
- VC is critical for new biotech firm
- Iomai files for $86.3M IPO
- Boston Life Sciences appoints Chief Medical Officer
- Human Genome Sciences gets anthrax drug contract
- Idenix May Have 'Best-In-Class' Hepatitis Treatment
- Chiron and Nektar Announce Initiation of Phase III Clinical Program Evaluating Tobramycin Inhalation Powder in Cystic Fibrosis Patients 1st of 2 Pivotal Trials Begins, 2nd Planned for 2006